| Highbridge Capital Management, LLC |
State of Delaware |
0 |
406250 |
0 |
0 |
406250 |
5.3 % |
14/11/2024 |
| Highbridge Capital Management, LLC |
State of Delaware |
0 |
406250 |
0 |
0 |
406250 |
5.3 % |
14/11/2024 |
| Aquilo Capital Management, LLC |
Delaware |
0 |
662659 |
0 |
0 |
662659 |
9.9 % |
18/03/2024 |
| Aquilo Capital Management, LLC |
California |
0 |
662659 |
0 |
0 |
662659 |
9.9 % |
18/03/2024 |
| Aquilo Capital, L.P. |
Delaware |
0 |
466767 |
0 |
0 |
466767 |
7.1 % |
18/03/2024 |
| Marc Schneidman |
United States |
0 |
662659 |
0 |
0 |
662659 |
9.9 % |
18/03/2024 |
| Marc Schneidman |
Delaware |
0 |
662659 |
0 |
0 |
662659 |
9.9 % |
18/03/2024 |
| Aquilo Capital, L.P. |
Delaware |
0 |
466767 |
0 |
0 |
466767 |
7.1 % |
18/03/2024 |
| Perceptive Life Sciences Master Fund, Ltd. |
Delaware |
0 |
500000 |
0 |
500000 |
500000 |
7.9 % |
14/03/2024 |
| Perceptive Life Sciences Master Fund, Ltd. |
Delaware |
0 |
500000 |
0 |
500000 |
500000 |
7.9 % |
14/03/2024 |
| Joseph Edelman |
Delaware |
0 |
500000 |
0 |
500000 |
500000 |
7.9 % |
14/03/2024 |
| Perceptive Advisors LLC |
Delaware |
0 |
500000 |
0 |
500000 |
500000 |
7.9 % |
14/03/2024 |
| Joseph Edelman |
Delaware |
0 |
500000 |
0 |
500000 |
500000 |
7.9 % |
14/03/2024 |
| Perceptive Advisors LLC |
Delaware |
0 |
500000 |
0 |
500000 |
500000 |
7.9 % |
14/03/2024 |
| EIN #00-0000000 |
Jersey, Channel Islands |
0 |
511108 |
0 |
511108 |
511108 |
8 % |
11/03/2024 |
| 00-0000000 |
Cayman Islands |
0 |
511108 |
0 |
511108 |
511108 |
8 % |
11/03/2024 |
| Tang Capital Management, LLC |
DELAWARE |
0 |
6400000 |
0 |
6400000 |
6400000 |
5.2 % |
05/02/2024 |
| Tang Capital Management, LLC |
DELAWARE |
0 |
6400000 |
0 |
6400000 |
6400000 |
5.2 % |
05/02/2024 |
| Dr. Jeffrey R. Jay, M.D. |
USA |
0 |
8099799 |
0 |
0 |
8099799 |
7.3 % |
27/02/2023 |
| Dr. Jeffrey R. Jay, M.D. |
Delaware |
0 |
8099799 |
0 |
0 |
8099799 |
7.3 % |
27/02/2023 |
| Mr. Ortav Yehudai |
Delaware |
0 |
8099799 |
0 |
0 |
8099799 |
7.3 % |
27/02/2023 |
| Mr. Ortav Yehudai |
USA |
0 |
8099799 |
0 |
0 |
8099799 |
7.3 % |
27/02/2023 |
| Great Point Partners, LLC |
Delaware |
0 |
8099799 |
0 |
0 |
8099799 |
7.3 % |
27/02/2023 |
| Great Point Partners, LLC |
Delaware |
0 |
8099799 |
0 |
0 |
8099799 |
7.3 % |
27/02/2023 |
| Derek Jantz |
U.S. |
4286638 |
0 |
4286638 |
4286638 |
4286638 |
3.9 % |
31/08/2022 |
| (1) BlackRock, Inc. |
Delaware |
2294278 |
0 |
2382569 |
0 |
2382569 |
2.4 % |
08/07/2022 |
| Dr. Jeffrey R. Jay, M.D. |
USA |
0 |
5755396 |
0 |
0 |
5755396 |
5.89 % |
01/07/2022 |
| Dr. Jeffrey R. Jay, M.D. |
Delaware |
0 |
5755396 |
0 |
0 |
5755396 |
5.89 % |
01/07/2022 |
| Great Point Partners, LLC |
Delaware |
0 |
5755396 |
0 |
0 |
5755396 |
5.89 % |
01/07/2022 |
| Mr. Ortav Yehudai |
Delaware |
0 |
5755396 |
0 |
0 |
5755396 |
5.89 % |
01/07/2022 |
| Great Point Partners, LLC |
Delaware |
0 |
5755396 |
0 |
0 |
5755396 |
5.89 % |
01/07/2022 |
| Mr. Ortav Yehudai |
USA |
0 |
5755396 |
0 |
0 |
5755396 |
5.89 % |
01/07/2022 |
| Novartis AG |
Switzerland |
0 |
12407440 |
0 |
12407440 |
12407440 |
16.6 % |
27/06/2022 |
| Novartis AG |
Switzerland |
0 |
12407440 |
0 |
12407440 |
12407440 |
16.6 % |
27/06/2022 |
| Novartis Pharma AG |
Switzerland |
0 |
12407440 |
0 |
12407440 |
12407440 |
16.6 % |
27/06/2022 |
| Novartis Pharma AG |
Switzerland |
0 |
12407440 |
0 |
12407440 |
12407440 |
16.6 % |
27/06/2022 |
| 95-1411037 |
Delaware |
4269000 |
0 |
4269000 |
0 |
13 |
7 % |
11/02/2022 |
| The Vanguard Group - 23-1945930 |
Pennsylvania For |
0 |
93098 |
0 |
0 |
3244286 |
5.34 % |
10/02/2022 |
| The Vanguard Group - 23-1945930 |
Pennsylvania For |
0 |
93098 |
0 |
0 |
3244286 |
5.34 % |
10/02/2022 |
| Derek Jantz |
U.S. |
4169315 |
0 |
4169315 |
0 |
4169315 |
6.8 % |
10/02/2022 |
| (1) BlackRock, Inc. |
Delaware |
4287853 |
0 |
4391514 |
0 |
4391514 |
7.2 % |
02/02/2022 |
| (1) BlackRock, Inc. |
Delaware |
3923178 |
0 |
4021111 |
0 |
4021111 |
7.7 % |
02/02/2021 |
| Eli Lilly and Company |
Indiana |
3762190 |
0 |
3762190 |
0 |
3762190 |
7.165 % |
08/01/2021 |
| Corey Goodman |
|
0 |
3739087 |
0 |
3739087 |
3739087 |
7.2 % |
08/06/2020 |
| venBio Global Strategic GP, L.P. |
|
0 |
3739087 |
0 |
3739087 |
3739087 |
7.2 % |
08/06/2020 |
| Robert Adelman |
|
0 |
3739087 |
0 |
3739087 |
3739087 |
7.2 % |
08/06/2020 |
| venBio Global Strategic GP, Ltd. |
|
0 |
3739087 |
0 |
3739087 |
3739087 |
7.2 % |
08/06/2020 |
| venBio Global Strategic Fund, L.P. |
|
0 |
3739087 |
0 |
3739087 |
3739087 |
7.2 % |
08/06/2020 |
| Derek Jantz |
|
4198624 |
0 |
4198624 |
0 |
4198624 |
8.2 % |
14/02/2020 |
| Derek Jantz |
U.S. |
4198624 |
0 |
4198624 |
0 |
4198624 |
8.2 % |
14/02/2020 |
| Capital World Investors ** |
Delaware |
4062000 |
0 |
4062000 |
0 |
4062000 |
7.9 % |
14/02/2020 |
| Capital World Investors ** |
|
4062000 |
0 |
4062000 |
0 |
4062000 |
7.9 % |
14/02/2020 |
| (1) BlackRock, Inc. |
Delaware |
2604357 |
0 |
2683428 |
0 |
2683428 |
5.3 % |
07/02/2020 |
| FMR LLC |
Delaware |
2446609 |
0 |
3738248 |
0 |
3738248 |
7.624 % |
03/04/2019 |
| FMR LLC |
Delaware |
2446609 |
0 |
3738248 |
0 |
3738248 |
7.624 % |
03/04/2019 |